MOLCURE will exhibit at BioJapan 2026, held at PACIFICO Yokohama from Wednesday, October 7, to Friday, October 9, 2026. Visit us at the Cabinet Office Pavilion, Booth A-06. On Thursday, October 8, from 11:00 AM to 12:00 PM JST, CEO/CSO Satoshi Tamaki will take the stage for a pitch at the booth.tehe stage fora

On Wednesday, October 7, from 1:30 PM JST, our Chief Innovation Officer (CIO) Ryu Ogawa will speak at the Japan Bioindustry Association (JBA) seminar, “New Modalities × AI-Driven Drug Discovery: Current Landscape and Future.” In his presentation, “The Frontier of AI-Driven Antibody Drug Discovery,” he will introduce MOLCURE’s AI antibody discovery platform, which combines its proprietary AI technologies with wet-lab experimentation. For more information, please visit the official seminar program.

We welcome attendees interested in AI-driven antibody discovery to connect with our team.